SAN DIEGO, CA / ACCESSWIRE / September 10, 2015 / MyDx, Inc. (OTCQB: MYDX), creator of MyDx(TM) (My Diagnostic), the first battery operated, handheld, chemical analyzer for consumers, is proud to announce that it has successfully transitioned from an R&D to a revenue generating company.
"We're very excited to announce that over the last 30 days, we have successfully recognized revenues through the sale and delivery of MyDx units to paid customers and recruited a seasoned team to help the company accelerate its growth in both the private and public markets going forward," said Founder Daniel Yazbeck, who served as interim CEO over the last month to better support the company's re-organization efforts. "Mr. Albert Hugo-Martinez has a track record of success in creating shareholder value with sizeable exits and we're especially excited to welcome him as our new CEO, effective today," continued Yazbeck, who will remain in his current role as Chairman and Chief Innovation Officer of the company.
"I joined MyDx because I believe in the company's mission, its products and potential to help mankind. I look forward to working closely with Daniel to continue to increase shareholder value by supporting the investor relations, product, marketing, sales, and customer service teams," said Albert Hugo-Martinez.
To learn more about Mr. Martinez or Mr. Yazbeck, please see their biographies below or visit www.cdxlife.com. Cannabis investors, analysts, executives, media, and consumers who would like to hear Mr. Martinez and Mr. Yazbeck give a free live online company presentation on Thursday, September 10, 2015 at 12:00 PM PDT, please visit Cannabis Investor Webcast's (http://www.cannawebcast.com/) Registration Page.
About MyDx, Inc. (MyDx Analyzer Video Link)
MyDx, Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California whose mission is to empower people to live a healthier life by revealing the purity of what they eat, drink and inhale in the palm of their hands and in real time. The Company has developed MyDx, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that will be compatible with the MyDx Analyzer and App. For more information, please visit www.cdxlife.com.
About Daniel Yazbeck
Daniel Yazbeck is the founder, seed investor and creator of the MyDx Analyzer. The Yazbeck Consulting & Investment Group, founded in 2007, supported the initial capital and resources required to drive the vision that is MyDx from concept to implementation. Daniel leverages nearly 15 years of additional experience with Fortune 500, as a Scientist for Pfizer Pharmaceuticals specializing in Chemical R&D technologies, and as a Strategic Market Developer for Panasonic, engineering new products for the consumer electronics healthcare industry. Daniel holds a Master's Degree in Medicinal Chemistry from McGill University with a minor in Marketing, and has co-authored several world patents and research publications.
Mr. Yazbeck will be a featured speaker at the upcoming Cannabis Investor Summit in Los Angeles on September 16th, 2015 at 2:30 p.m. PDT, where he will be discussing Cannabis Market Sector opportunities.
About Albert Hugo Martinez
Mr. Hugo-Martinez brings over 45 years of management experience in the electronics industry. He is the former CEO of Applied Micro Chip Corporation (NASDAQ:AMCC), and served on the Board of Directors of Microchip (NASDAQ:MCHP) for 24 years. He was the CEO of GTI Corporation (GGTI), managing 8000 employees in China, 3000 in the Philippines and 2000 in the United States, which he sold to Pulse Electronics. He has also served as chairman of Reaction Design, an alternative fuel simulation company, which was sold to ANSYS. He began his career as a technician at Motorola, rising to the position of Director of Analogue Semiconductor products, before his departure. He continued his ascent to become COO of Burr Brown Research (BBRC). He also was Sr. VP of TRW's (NYSE:TRW) three merchant market businesses and sold the Opto Division to OPTICS in Texas and the RF Division to Motorola. He holds an MSEE from the University of Arizona and a Motorola-sponsored two-year executive management MBA equivalent. He currently holds positions as a board member for iboss Cybersecurity, NetClearance Systems, Mobile Works, CouchLock, and Agrisource Data. Albert also served on the board of directors of the UCSD Cancer Institute.
Safe Harbor
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov.
Company Contact:
Jotti Dhillon
MyDx, Inc.
Jotti@cdxlife.com
800.814.4550
SOURCE: MyDx, Inc.
